HealthEquity (NASDAQ:HQY) Updates FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.870-3.950 for the period, compared to the consensus estimate of 3.690. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HQY. BTIG Research reduced their price target on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research report on Tuesday. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. UBS Group set a $110.00 price target on HealthEquity in a report on Tuesday. Barrington Research restated an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Finally, KeyCorp increased their price objective on shares of HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, January 8th. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $116.13.

HealthEquity Stock Performance

NASDAQ:HQY traded up $0.48 during midday trading on Tuesday, hitting $74.36. The company’s stock had a trading volume of 987,588 shares, compared to its average volume of 1,138,866. HealthEquity has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The firm has a market cap of $6.35 billion, a P/E ratio of 34.11, a P/E/G ratio of 0.92 and a beta of 0.24. The firm’s 50 day moving average is $88.03 and its 200-day moving average is $92.07.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same period in the prior year, the firm earned $0.78 EPS. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,959 shares of company stock valued at $1,344,957 in the last quarter. Company insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

Institutional investors and hedge funds have recently made changes to their positions in the business. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity during the 4th quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd acquired a new position in HealthEquity during the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd lifted its holdings in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of HealthEquity by 190.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after purchasing an additional 396 shares during the period. Finally, Larson Financial Group LLC increased its stake in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.